...
首页> 外文期刊>Cellular Physiology and Biochemistry >Liver Kinase B1/AMP-Activated Protein Kinase Pathway Activation Attenuated the Progression of Endotoxemia in the Diabetic Mice
【24h】

Liver Kinase B1/AMP-Activated Protein Kinase Pathway Activation Attenuated the Progression of Endotoxemia in the Diabetic Mice

机译:肝激酶B1 / AMP激活的蛋白激酶途径激活减弱了糖尿病小鼠内毒素血症的进展。

获取原文

摘要

>Background/Aims: Sepsis is a common disease that continues to increase in prevalence worldwide, and diabetes mellitus may make the situation worse. This study was designed to determine the role of Liver Kinase B1 (LKB1)/adenosine monophosphate-activated protein kinase (AMPK) signaling pathway in diabetic mice complicated with systemic endotoxemia. Methods: The effects of LKB1/AMPK signaling pathway activation on endotoxemia were investigated in streptozotocin induced diabetic mice (STZ-mice) and db/db diabetic mice. Primary peritoneal macrophages and human umbilical vein endothelial cells (HUVECs) monolayers were simultaneously stimulated by both high glucose and LPS and used as a model to investigate the potential molecular mechanisms in vitro. Results: After treatment with LPS, high glucose or both LPS and high glucose, phosphor-AMPK expression was decreased, and moreover, AMPK activation by metformin treatment alleviated the decrease in phosphor-AMPK expression in HUVECs and macrophages as well as in lung tissue. Furthermore, both LPS and high glucose co-treatment decreased LKB1 and phosphor-AMPK expression via enhanced oxidative stress response, and importantly, LKB1 overexpression mediated by adenovirus inhibited the decrease in phosphor-AMPK expression in macrophages and HUVECs. AMPK activation by metformin administration improved the survival of STZ-induced diabetic mice and db/db diabetic mice, which was associated with reduced lung endothelial hyperpermeability and systemic inflammatory response. Furthermore, the permeability of HUVECs monolayers induced by both high glucose and LPS stimulation was also alleviated by AMPK activation, which was partly via suppression of VE-cadherin phosphorylation. Conclusion: These data demonstrated that LKB1/AMPK signaling pathway activation improved the survival of diabetic mice complicated with endotoxemia. Thus, LKB1/AMPK signaling pathway may serve as a potentially useful therapeutic target for severe infection in diabetic patients.
机译:> 背景/目标: 脓毒症是一种普遍的疾病,在世界范围内患病率持续上升,而糖尿病可能会使情况变得更糟。这项研究旨在确定在并发系统性内毒素血症的糖尿病小鼠中肝激酶B1(LKB1)/单磷酸腺苷激活蛋白激酶(AMPK)信号通路的作用。 方法: 在链脲佐菌素诱导的糖尿病小鼠(STZ-小鼠)和db / db糖尿病小鼠中研究了LKB1 / AMPK信号通路激活对内毒素血症的影响。高糖和脂多糖同时刺激原代腹膜巨噬细胞和人脐静脉内皮细胞(HUVECs)单层,并用作研究潜在分子机制的模型体外 结果: 用LPS,高糖或LPS和高葡萄糖同时处理后,磷光体的AMPK表达降低,此外,二甲双胍处理激活AMPK减轻了磷光体的减少-AMPK在HUVEC和巨噬细胞以及肺组织中的表达。此外,LPS和高糖共同处理均通过增强的氧化应激反应降低了LKB1和磷-AMPK表达,重要的是,腺病毒介导的LKB1过表达抑制了巨噬细胞和HUVEC中磷-AMPK表达的降低。通过二甲双胍的给药激活AMPK可以改善STZ诱导的糖尿病小鼠和db / db糖尿病小鼠的存活率,这与降低的肺内皮通透性和全身性炎症反应有关。此外,AMPK激活也减轻了高葡萄糖和LPS刺激诱导的HUVECs单层的通透性,这部分是通过抑制VE-钙黏着蛋白的磷酸化来实现的。 结论: 这些数据表明,LKB1 / AMPK信号通路激活可改善并发内毒素血症的糖尿病小鼠的存活率。因此,LKB1 / AMPK信号通路可作为糖尿病患者严重感染的潜在有用治疗靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号